Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
---|---|---|---|---|---|
ASTRAZENECA | 10 | 22 | -0,71 % | ||
ABB | 5 | 18 | +0,07 % | ||
ERICSSON | 3 | 20 | -0,06 % | ||
BOLIDEN | 3 | - | +0,36 % | ||
HEXAGON | 2 | 9 | +0,39 % | ||
VOLVO | 1 | 17 | +0,21 % | ||
EQT AB | 1 | 6 | -0,03 % | ||
SAAB | 1 | 5 | -0,01 % | ||
ESSITY AB B | 1 | 2 | -0,09 % | ||
SWEDBANK | 1 | - | +0,58 % |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
01:26 | AstraZeneca PLC (AZN)'s Datroway Wins FDA Nod for Lung Cancer Breakthrough | 2 | Insider Monkey | ||
00:06 | AstraZeneca's Multi-Billion Dollar Cancer Drug Tagrisso Improves Overall Survival In Patients With Advanced Lung Cancer | 5 | Benzinga.com | ||
00:00 | AstraZeneca plans to invest $50B in U.S. by 2030 | 7 | Seeking Alpha | ||
Mo | AstraZeneca unveils $50 billion US investment as pharma tariff threat looms | 2 | Reuters | ||
Mo | AstraZeneca, facing lung cancer challenge from J&J, touts life extension benefit for Tagrisso combo | 4 | FiercePharma | ||
Mo | Deutsche Bank Research erhöht Kursziel für ABB, äußert aber weiterhin Vorbehalte | 30 | InvestmentWeek | ||
Mo | Former regulator Martin Noréus appointed new Swedbank CRO | 3 | FinTech Futures | ||
Mo | Research and Markets: Europe Glucagon-like Peptide-1 (GLP-1) Agonists Market Report 2025-2034 Featuring Eli Lilly and Co, Sanofi" Novo Nordisk, and AstraZeneca - ResearchAndMarkets.com | 329 | Business Wire | The "Europe Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034" has been added to ResearchAndMarkets.com's offering.
The Europe glucagon-like peptide-1 (GLP-1) agonists... ► Artikel lesen | |
Mo | Ooredoo Kuwait picks Ericsson for BSS update | 3 | Mobile World Live | ||
Mo | Renault Trucks E-Tech Master: Mit Bike und E-Van über alle Berge | 5 | VISION mobility | ||
Mo | Ooredoo Kuwait Partners with Ericsson to Advance 5G Monetisation with Cloud-Native Charging | 3 | TechAfrica News | ||
Mo | Ericsson to cut 300 jobs in Spain - report | 3 | DatacenterDynamics | ||
Mo | AstraZeneca: Kombinationstherapie mit Lungenkrebsmedikament verlängert Überleben | 16 | Investing.com Deutsch | ||
Mo | Citi upgrades ABB to "buy" on margin upside, higher growth outlook | 14 | Investing.com | ||
Mo | AstraZeneca's lung cancer drug shows improved survival with chemotherapy combo | 6 | Investing.com | ||
Mo | AstraZeneca shares late-stage results for Tagrisso combination in lung cancer | 7 | PMLiVE | ||
Mo | DEUTSCHE BANK RESEARCH stuft ABB LTD auf 'Sell' | 409 | dpa-AFX-Analyser | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für ABB von 42 auf 45 Franken angehoben, aber die Einstufung auf "Sell" belassen. Die jüngsten, starken Quartalszahlen des Industriekonzerns... ► Artikel lesen | |
Mo | JPMORGAN stuft ASTRAZENECA auf 'Overweight' | 384 | dpa-AFX-Analyser | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Astrazeneca auf "Overweight" mit einem Kursziel von 14000 Pence belassen. Dass das Medikament Tagrisso in Kombination mit einer Chemotherapie eine... ► Artikel lesen | |
Mo | Berenberg upgrades Boliden to "buy" on FCF recovery and operational turn | 10 | Investing.com | ||
Mo | EQT to Acquire Adevinta's Spanish Online Classifieds Businesses | 198 | PR Newswire | The EQT X fund has agreed to acquire Adevinta's Spanish operations ("Adevinta Spain"), including leading Spanish online classifieds platforms such as Coches.net, InfoJobs, Milanuncios, Fotocasa... ► Artikel lesen |